GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $146 | +25.9% | 57 | 0.0% | 0.00% | – |
| Q4 2023 | $116 | -99.3% | 57 | -99.4% | 0.00% | – |
| Q3 2023 | $17,200 | -11.8% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $19,500 | -29.9% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $27,800 | -19.4% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $34,500 | +32.7% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | +8.3% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | -41.5% | 10,000 | -0.4% | 0.00% | – |
| Q1 2022 | $41,000 | +4000.0% | 10,044 | +22727.3% | 0.00% | – |
| Q4 2021 | $1,000 | – | 44 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 44 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 44 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 44 | -25.4% | 0.00% | – |
| Q4 2020 | $0 | – | 59 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,005,894 | $43,264,000 | 17.91% |
| FRAZIER MANAGEMENT LLC | 4,667,242 | $50,406,000 | 4.03% |
| EcoR1 Capital, LLC | 5,560,748 | $60,056,000 | 2.09% |
| Palo Alto Investors LP | 2,356,282 | $25,448,000 | 1.54% |
| Avidity Partners Management LP | 4,457,831 | $48,145,000 | 1.07% |
| BVF INC/IL | 1,528,072 | $16,503,000 | 0.64% |
| Redmile Group, LLC | 2,821,085 | $30,468,000 | 0.53% |
| ACT CAPITAL MANAGEMENT, LLC | 74,000 | $799,000 | 0.41% |
| DG Capital Management, LLC | 83,162 | $898,000 | 0.18% |
| HighVista Strategies LLC | 14,453 | $156,000 | 0.10% |